Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | |
| Format: | Thesis |
| Jezik: | English |
| Izdano: |
Brac University
2022
|
| Teme: | |
| Online dostop: | http://hdl.handle.net/10361/17301 |
| id |
10361-17301 |
|---|---|
| record_format |
dspace |
| spelling |
10361-173012022-09-26T21:01:58Z Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers Pranto, Hasan Al Reza Afrose, Afrina Department of Pharmacy, Brac University Heterologous vaccination Neutralizing- antibody Mutation Prime dose Booster dose This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 37-44). The ongoing COVID-19 pandemic has been going on since 2019 and has spread throughout the world’s region. To fight of COVID-19 virus, different vaccine Manufacturer Company has come up with different types of vaccines that include AstraZeneca, Pfizer/BNT Moderna, Sinovac etc. Vaccines are comprised of two vaccine regimens, the initial dose as prime dose and the second dose shot as a booster dose. A booster dose is important to produce enough antibodies to neutralize the COVID-19 virus. In the meantime, the virus has mutated several times and became more deadly. This study finds that a better immune response can be generated if two different types of vaccines are mixed and used as an initial and second dose. The immune system produces more virus-killing antibodies than single-brand vaccines used as an initial and subsequent dose. The side effects of such vaccination are found quite normal. The issue of vaccine shortage can also be overcome by such mixed vaccination. Some countries have failed to secure the buy of a single brand vaccine in large numbers, they can provide the second and further doses with the vaccine they have in their inventory in such vaccination procedure. They will have an option to provide a second dose with a different brand vaccine if they face any potential vaccine shortage. Heterologous vaccination will prove additional security from the new and deadly COVID-19 variants with enhanced immune protection as interpreted by some research. Hasan Al Reza Pranto B. Pharmacy 2022-09-26T04:53:35Z 2022-09-26T04:53:35Z 2022 2021-12 Thesis ID 16346005 http://hdl.handle.net/10361/17301 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 44 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Heterologous vaccination Neutralizing- antibody Mutation Prime dose Booster dose |
| spellingShingle |
Heterologous vaccination Neutralizing- antibody Mutation Prime dose Booster dose Pranto, Hasan Al Reza Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. |
| author2 |
Afrose, Afrina |
| author_facet |
Afrose, Afrina Pranto, Hasan Al Reza |
| format |
Thesis |
| author |
Pranto, Hasan Al Reza |
| author_sort |
Pranto, Hasan Al Reza |
| title |
Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers |
| title_short |
Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers |
| title_full |
Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers |
| title_fullStr |
Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers |
| title_full_unstemmed |
Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers |
| title_sort |
potential benefits of heterologous mixture of covid 19 vaccinations from different manufacturers |
| publisher |
Brac University |
| publishDate |
2022 |
| url |
http://hdl.handle.net/10361/17301 |
| work_keys_str_mv |
AT prantohasanalreza potentialbenefitsofheterologousmixtureofcovid19vaccinationsfromdifferentmanufacturers |
| _version_ |
1814308004862885888 |